162 related articles for article (PubMed ID: 35370661)
1. Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer.
Fu Z; Li S; Liu J; Zhang C; Jian C; Wang L; Zhang Y; Shi C
Front Pharmacol; 2022; 13():847906. PubMed ID: 35370661
[TBL] [Abstract][Full Text] [Related]
2. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
[TBL] [Abstract][Full Text] [Related]
3. AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming.
Chang LL; Lu PH; Yang W; Hu Y; Zheng L; Zhao Q; Lin NM; Zhang WZ
Transl Oncol; 2022 Jun; 20():101421. PubMed ID: 35429904
[TBL] [Abstract][Full Text] [Related]
4. The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.
Zhu H; Hu Y; Zeng C; Chang L; Ge F; Wang W; Yan F; Zhao Q; Cao J; Ying M; Gu Y; Zheng L; He Q; Yang B
Theranostics; 2020; 10(5):2188-2200. PubMed ID: 32104503
[TBL] [Abstract][Full Text] [Related]
5. AKR1C1 connects autophagy and oxidative stress by interacting with SQSTM1 in a catalytic-independent manner.
Chang LL; Li YK; Zhao CX; Zeng CM; Ge FJ; Du JM; Zhang WZ; Lu PH; He QJ; Zhu H; Yang B
Acta Pharmacol Sin; 2022 Mar; 43(3):703-711. PubMed ID: 34017066
[TBL] [Abstract][Full Text] [Related]
6. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
Chun J; Li RJ; Cheng MS; Kim YS
Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
[TBL] [Abstract][Full Text] [Related]
7. Wentilactone A induces cell apoptosis by targeting AKR1C1 gene via the IGF-1R/IRS1/PI3K/AKT/Nrf2/FLIP/Caspase-3 signaling pathway in small cell lung cancer.
Jiang W; Meng L; Xu G; Lv C; Wang H; Tian H; Chen R; Jiao B; Wang B; Huang C
Oncol Lett; 2018 Nov; 16(5):6445-6457. PubMed ID: 30405782
[TBL] [Abstract][Full Text] [Related]
8. Liquiritin, as a Natural Inhibitor of AKR1C1, Could Interfere With the Progesterone Metabolism.
Zeng C; Zhu D; You J; Dong X; Yang B; Zhu H; He Q
Front Physiol; 2019; 10():833. PubMed ID: 31333491
[TBL] [Abstract][Full Text] [Related]
9. Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
Matsumoto R; Tsuda M; Yoshida K; Tanino M; Kimura T; Nishihara H; Abe T; Shinohara N; Nonomura K; Tanaka S
Sci Rep; 2016 Oct; 6():34625. PubMed ID: 27698389
[TBL] [Abstract][Full Text] [Related]
10. Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin.
Wang HW; Lin CP; Chiu JH; Chow KC; Kuo KT; Lin CS; Wang LS
Int J Cancer; 2007 May; 120(9):2019-27. PubMed ID: 17266043
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer.
Huang F; Zheng Y; Li X; Luo H; Luo L
Cancer Cell Int; 2021 Oct; 21(1):567. PubMed ID: 34702254
[TBL] [Abstract][Full Text] [Related]
12. AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression.
Wei X; Wei Z; Li Y; Tan Z; Lin C
Biochem Genet; 2021 Apr; 59(2):516-530. PubMed ID: 33170398
[TBL] [Abstract][Full Text] [Related]
13. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
[TBL] [Abstract][Full Text] [Related]
14. AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway.
Wang X; Yang B; Li Y; Luo J; Wang Y
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34590152
[TBL] [Abstract][Full Text] [Related]
15. Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling.
Gao Y; Xu D; Li H; Xu J; Pan Y; Liao X; Qian J; Hu Y; Yu G
Front Oncol; 2021; 11():677678. PubMed ID: 34127944
[TBL] [Abstract][Full Text] [Related]
16. High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells.
Tian H; Li X; Jiang W; Lv C; Sun W; Huang C; Chen R
Lung Cancer (Auckl); 2016; 7():53-61. PubMed ID: 28210161
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1).
El-Kabbani O; Dhagat U; Hara A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):105-11. PubMed ID: 21050889
[TBL] [Abstract][Full Text] [Related]
18. Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): Functions, regulation, and structural insights of inhibitors.
Chu X; He S; Liu Y; Liu Y; Feng F; Guo Q; Zhao L; Sun H
Chem Biol Interact; 2022 Jan; 351():109746. PubMed ID: 34780792
[TBL] [Abstract][Full Text] [Related]
19. Expression of aldo-keto reductase family 1 member C1 (AKR1C1) gene in porcine ovary and uterine endometrium during the estrous cycle and pregnancy.
Seo KS; Naidansuren P; Kim SH; Yun SJ; Park JJ; Sim BW; Park CW; Nanjidsuren T; Kang MH; Seo H; Ka H; Kim NH; Hwang SY; Yoon JT; Yamanouchi K; Min KS
Reprod Biol Endocrinol; 2011 Oct; 9():139. PubMed ID: 22014308
[TBL] [Abstract][Full Text] [Related]
20. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
